1992
Serologic evidence of active Epstein-barr virus infection in epstein-barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome
Katz B, Berkman A, Shapiro E. Serologic evidence of active Epstein-barr virus infection in epstein-barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. The Journal Of Pediatrics 1992, 120: 228-232. PMID: 1310507, DOI: 10.1016/s0022-3476(05)80432-9.Peer-Reviewed Original ResearchConceptsEpstein-Barr virusLymphocytic interstitial pneumonitisNon-Hodgkin lymphomaCase patientsImmunodeficiency syndromeControl patientsSerologic evidenceEBV infectionInterstitial pneumonitisVirus infectionIndex patientsEpstein-Barr virus-associated lymphoproliferative disorderActive Epstein-Barr virus infectionEpstein-Barr virus infectionHuman immunodeficiency virus (HIV) infectionIndex case patientsActive EBV infectionImmunodeficiency virus infectionCase-control studySpecimens of tissueVirologic evidenceLymphoproliferative disordersSerologic profilePatientsPneumonitis
1991
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro E, Berg A, Austrian R, Schroeder D, Parcells V, Margolis A, Adair R, Clemens J. The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine. New England Journal Of Medicine 1991, 325: 1453-1460. PMID: 1944423, DOI: 10.1056/nejm199111213252101.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal infectionsPneumococcal polysaccharide vaccinePneumococcal vaccineProtective efficacyPneumococcal infectionCase patientsImmunocompetent patientsPolysaccharide vaccineVaccination historyHospital-based case-control studyPolyvalent pneumococcal polysaccharide vaccineSerious pneumococcal infectionsSite of hospitalizationVaccine protective efficacyPolyvalent pneumococcal vaccineCase-control studyProspective surveillanceRandomized trialsSterile sitesPatientsS. pneumoniaeMedical careStreptococcus pneumoniaeVaccineInfection